-
of Drs. Zhuolin Liu and Daniel X. Hammer at the Food and Drug Administration (FDA) to perform clinically oriented research projects related to the use of this technology to better understand and monitor
-
underlying mechanisms; 2) glycol-engineered neural stem cells to improve brain outcome after cardiac arrest. 3) Stem cell surface modification to promote nerve regeneration after peripheral nerve injuries
-
record. Lab interests: 1) brain recovery after cardiac arrest with stem cell therapy, extracellular vehicle therapy, or therapeutic hypothermia and underlying mechanisms; 2) glycol-engineered neural stem
-
Qualifications and Skills Ph.D. in Medical Physics, Physics, Mathematics, Electrical Engineering, Computer Science, Biomedical Engineering, or a related field is required. Expertise is required or highly desired
-
to accelerate the translation of AO imaging technology to wide-spread clinical use. The candidate will be also expected to provide analysis support for collaborative team members. Qualifications An ambitious
-
laboratories and cutting-edge technology. Career development support and training opportunities will be available within the lab and through the Center for Advanced Research Training and Innovation https
-
record. Lab interests: 1) brain recovery after cardiac arrest with stem cell therapy, extracellular vehicle therapy, or therapeutic hypothermia and underlying mechanisms; 2) glycol-engineered neural stem
-
stem cell technology to develop vascular and alveolar tissue models. This excellent research opportunity will provide extensive training in cellular and molecular biology, bioengineering, and
-
of human thoracic aortic disease. Our laboratory within the Division of Cardiac Surgery in the School of Medicine and in direct collaboration with bioengineers within the A. James Clark School of Engineering
-
scientific environment at University of Maryland, Baltimore and surrounding institutions such as school of e engineering at college park offers ample opportunity for productive collaborations. We expect